The Latest Breaking News from KimberlyClark

Kimberly-Clark is set to announce its fourth-quarter earnings later this month, with analysts projecting a slight decline in earnings.

Kimberly-Clark has underperformed the Dow Jones Industrial in recent trading, yet analysts maintain a moderately optimistic outlook for the stock's future.

Selling the December 142-strike call option generates an income of 0.61% in just under one month, equaling around 9% annualized.

Kimberly-Clark has underperformed the broader market over the past year, yet analysts maintain a reasonably bullish stance on its future prospects.

Kimberly-Clark is expected to release its third-quarter earnings later this month, and analysts expect a single-digit earnings dip.

Kimberly-Clark has outperformed the Nasdaq Composite recently, and analysts remain moderately bullish about the stock’s prospects.

Kimberly-Clark has underperformed the broader market over the past year, and analysts remain cautiously bullish on the stock’s prospects.

Rising costs of sanitary pads and tampons in the U.S. have exacerbated period poverty, with many women incurring debt to afford essential products amid growing safety concerns over detected toxic metals.

Despite Kimberly-Clark’s mixed performance relative to the broader S&P 500 Index, Wall Street analysts remain cautiously optimistic about the stock’s outlook.

Kimberly-Clark, a Dividend King with a 52-year dividend growth streak, just received a double upgrade following strong Q1 results, signaling a potential turnaround for the company. With a new consensus 'Buy' rating from analysts, KMB could be a solid addition to your portfolio.

Kimberly-Clark recently purchased Thinx, laying off 60% of employees at the former direct-to-consumer darling.